Initial experience of ultrasound‐guided radiofrequency ablation of benign symptomatic thyroid nodules: Safety and short‐term efficacy

Aim To report the safety and short‐term efficacy of the use of ultrasound‐guided radiofrequency ablation (RFA) for benign symptomatic thyroid nodules. Methods The treatment outcomes of patients who were treated with RFA for benign symptomatic thyroid nodules from December 2017 to December 2019 were...

Full description

Saved in:
Bibliographic Details
Published in:Surgical practice 2022-02, Vol.26 (1), p.15-18
Main Authors: Ho, Tsit‐Lai, Tai, Dora K. C., Chick, Wai‐Keung, Chiang, Betsy J., Kwok, Philip C. H.
Format: Article
Language:English
Subjects:
Ablation
Cysts
Thyroid gland
Ultrasonic imaging
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aim To report the safety and short‐term efficacy of the use of ultrasound‐guided radiofrequency ablation (RFA) for benign symptomatic thyroid nodules. Methods The treatment outcomes of patients who were treated with RFA for benign symptomatic thyroid nodules from December 2017 to December 2019 were retrospectively reviewed. Nodule volumes were assessed before treatment, and at 1, 6 and 12 months after treatment for comparison. Complications were reported. Results A total of 18 patients were treated. The volume reduction rate at 1, 6 and 12 months were 39.6% ± 23.4%, 60.02% ± 18.40% and 70.18% ± 22.68%, respectively. The rate of treatment success was 33.3%, 72.2% and 81.8%, respectively. Statistically significant reductions were noted in volume at all three time points (all with P 
ISSN:1744-1625
1744-1633
DOI:10.1111/1744-1633.12553